ParkinsonCanadaV1, Main, Exploration, bibRecord, 001515

Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs

Identifieur interne : 001515 ( Main/Exploration ); précédent : 001514; suivant : 001516

Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs

Auteurs : Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Jenna Sykes [Canada] ; Stephen J. Kish [Canada]

Source :

Drug and alcohol dependence [ 0376-8716 ] ; 2012.

RBID : Pascal:12-0064798

Descripteurs français

Pascal (Inist)
- Métamfétamine, Facteur risque, Maladie de Parkinson, Amfétamine, Homme, Individu, Trouble motricité, Milieu hospitalier, Utilisation, Trouble moteur, Médicament, Incidence, Addiction, Santé publique, Dopamine, Cocaïne, Etude cohorte, Toxicomanie, Psychotrope, Stimulant SNC, Substance toxicomanogène.
Wicri :
- topic : Homme, Médicament, Santé publique, Toxicomanie.

English descriptors

KwdEn :
- Addiction, Amfetamine, CNS stimulant, Cocaine, Cohort study, Dopamine, Drug, Drug addiction, Drug of abuse, Hospital environment, Human, Incidence, Individual, Metamfetamine, Motility disorder, Motor system disorder, Parkinson disease, Psychotropic, Public health, Risk factor, Use.

Abstract

Background: Since methamphetamine and other amphetamine-type stimulants (meth/amphetamine) can damage dopaminergic neurons, researchers have long speculated that these drugs may predispose users to develop Parkinson's disease (PD), a dopamine deficiency neurological disorder. Methods: We employed a retrospective population-based cohort study using all linked statewide California inpatient hospital episodes and death records from January 1, 1990 through December 31, 2005. Patients at least 30 years of age were followed for up to 16 years. Competing risks analysis was used to determine whether the meth/amphetamine cohort had elevated risk of developing PD (ICD-9 332.0; ICD-10 G20) in comparison to a matched population-proxy appendicitis group and a matched cocaine drug control group. Individuals admitted to hospital with meth/amphetamine-related conditions (n = 40,472; ICD-9 codes 304.4, 305.7, 969.7, E854.2) were matched on age, race, sex, date of index admission, and patterns of hospital admission with patients with appendicitis conditions (n = 207,83 1; ICD-9 codes 540-542) and also individuals with cocaine-use disorders (n = 35,335; ICD-9 codes 304.2, 305.6, 968.5). Results: The meth/amphetamine cohort showed increased risk of PD compared to both that of the matched appendicitis group [hazard ratio (HR) = 1.76, 95% CI: 1.12-2.75, p = 0.017] and the matched cocaine group [HR ₌ 2.44,95% CI: 1.32-4.41, p=0.004]. The cocaine group did not show elevated hazard of PD compared to the matched appendicitis group [HR = 1.04, 95% CI: 0.56-1.93, p = 0.80]. Conclusion: These data provide evidence that meth/amphetamine users have above-normal risk for developing PD.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000235
to stream PascalFrancis, to step Corpus: 000262
to stream PascalFrancis, to step Curation: 000A17
to stream PascalFrancis, to step Checkpoint: 000148
to stream Main, to step Merge: 001562
to stream Main, to step Curation: 001515

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs</title>
<author><name sortKey="Callaghan, Russell C" sort="Callaghan, Russell C" uniqKey="Callaghan R" first="Russell C." last="Callaghan">Russell C. Callaghan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 33 Russell St</s1>
<s2>Toronto, ON M5S 2S1</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, ON M5S 2S1</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Dalla Lana School of Public Health, University of Toronto</s1>
<s2>Toronto, ON M5T 3M7</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Cunningham, James K" sort="Cunningham, James K" uniqKey="Cunningham J" first="James K." last="Cunningham">James K. Cunningham</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Family and Community Medicine, The University of Arizona</s1>
<s2>Tucson, AZ 85719</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Tucson, AZ 85719</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sykes, Jenna" sort="Sykes, Jenna" uniqKey="Sykes J" first="Jenna" last="Sykes">Jenna Sykes</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 33 Russell St</s1>
<s2>Toronto, ON M5S 2S1</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, ON M5S 2S1</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kish, Stephen J" sort="Kish, Stephen J" uniqKey="Kish S" first="Stephen J." last="Kish">Stephen J. Kish</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 33 Russell St</s1>
<s2>Toronto, ON M5S 2S1</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, ON M5S 2S1</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Departments of Psychiatry and Pharmacology, University of Toronto</s1>
<s2>Toronto, ON M5A 2N4</s2>
<s3>CAN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0064798</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0064798 INIST</idno>
<idno type="RBID">Pascal:12-0064798</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000235</idno>
<idno type="stanalyst">FRANCIS 12-0064798 INIST</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000262</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000A17</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000148</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000148</idno>
<idno type="wicri:doubleKey">0376-8716:2012:Callaghan R:increased:risk:of</idno>
<idno type="wicri:Area/Main/Merge">001562</idno>
<idno type="wicri:Area/Main/Curation">001515</idno>
<idno type="wicri:Area/Main/Exploration">001515</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs</title>
<author><name sortKey="Callaghan, Russell C" sort="Callaghan, Russell C" uniqKey="Callaghan R" first="Russell C." last="Callaghan">Russell C. Callaghan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 33 Russell St</s1>
<s2>Toronto, ON M5S 2S1</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, ON M5S 2S1</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Dalla Lana School of Public Health, University of Toronto</s1>
<s2>Toronto, ON M5T 3M7</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author><name sortKey="Cunningham, James K" sort="Cunningham, James K" uniqKey="Cunningham J" first="James K." last="Cunningham">James K. Cunningham</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Family and Community Medicine, The University of Arizona</s1>
<s2>Tucson, AZ 85719</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Tucson, AZ 85719</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sykes, Jenna" sort="Sykes, Jenna" uniqKey="Sykes J" first="Jenna" last="Sykes">Jenna Sykes</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 33 Russell St</s1>
<s2>Toronto, ON M5S 2S1</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, ON M5S 2S1</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kish, Stephen J" sort="Kish, Stephen J" uniqKey="Kish S" first="Stephen J." last="Kish">Stephen J. Kish</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 33 Russell St</s1>
<s2>Toronto, ON M5S 2S1</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, ON M5S 2S1</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Departments of Psychiatry and Pharmacology, University of Toronto</s1>
<s2>Toronto, ON M5A 2N4</s2>
<s3>CAN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Drug and alcohol dependence</title>
<title level="j" type="abbreviated">Drug and alcohol depend.</title>
<idno type="ISSN">0376-8716</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Drug and alcohol dependence</title>
<title level="j" type="abbreviated">Drug and alcohol depend.</title>
<idno type="ISSN">0376-8716</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Addiction</term>
<term>Amfetamine</term>
<term>CNS stimulant</term>
<term>Cocaine</term>
<term>Cohort study</term>
<term>Dopamine</term>
<term>Drug</term>
<term>Drug addiction</term>
<term>Drug of abuse</term>
<term>Hospital environment</term>
<term>Human</term>
<term>Incidence</term>
<term>Individual</term>
<term>Metamfetamine</term>
<term>Motility disorder</term>
<term>Motor system disorder</term>
<term>Parkinson disease</term>
<term>Psychotropic</term>
<term>Public health</term>
<term>Risk factor</term>
<term>Use</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Métamfétamine</term>
<term>Facteur risque</term>
<term>Maladie de Parkinson</term>
<term>Amfétamine</term>
<term>Homme</term>
<term>Individu</term>
<term>Trouble motricité</term>
<term>Milieu hospitalier</term>
<term>Utilisation</term>
<term>Trouble moteur</term>
<term>Médicament</term>
<term>Incidence</term>
<term>Addiction</term>
<term>Santé publique</term>
<term>Dopamine</term>
<term>Cocaïne</term>
<term>Etude cohorte</term>
<term>Toxicomanie</term>
<term>Psychotrope</term>
<term>Stimulant SNC</term>
<term>Substance toxicomanogène</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Médicament</term>
<term>Santé publique</term>
<term>Toxicomanie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Since methamphetamine and other amphetamine-type stimulants (meth/amphetamine) can damage dopaminergic neurons, researchers have long speculated that these drugs may predispose users to develop Parkinson's disease (PD), a dopamine deficiency neurological disorder. Methods: We employed a retrospective population-based cohort study using all linked statewide California inpatient hospital episodes and death records from January 1, 1990 through December 31, 2005. Patients at least 30 years of age were followed for up to 16 years. Competing risks analysis was used to determine whether the meth/amphetamine cohort had elevated risk of developing PD (ICD-9 332.0; ICD-10 G20) in comparison to a matched population-proxy appendicitis group and a matched cocaine drug control group. Individuals admitted to hospital with meth/amphetamine-related conditions (n = 40,472; ICD-9 codes 304.4, 305.7, 969.7, E854.2) were matched on age, race, sex, date of index admission, and patterns of hospital admission with patients with appendicitis conditions (n = 207,83 1; ICD-9 codes 540-542) and also individuals with cocaine-use disorders (n = 35,335; ICD-9 codes 304.2, 305.6, 968.5). Results: The meth/amphetamine cohort showed increased risk of PD compared to both that of the matched appendicitis group [hazard ratio (HR) = 1.76, 95% CI: 1.12-2.75, p = 0.017] and the matched cocaine group [HR <sub>=</sub>
 2.44,95% CI: 1.32-4.41, p=0.004]. The cocaine group did not show elevated hazard of PD compared to the matched appendicitis group [HR = 1.04, 95% CI: 0.56-1.93, p = 0.80]. Conclusion: These data provide evidence that meth/amphetamine users have above-normal risk for developing PD.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>États-Unis</li>
</country>
<region><li>Ontario</li>
</region>
<settlement><li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Callaghan, Russell C" sort="Callaghan, Russell C" uniqKey="Callaghan R" first="Russell C." last="Callaghan">Russell C. Callaghan</name>
</noRegion>
<name sortKey="Callaghan, Russell C" sort="Callaghan, Russell C" uniqKey="Callaghan R" first="Russell C." last="Callaghan">Russell C. Callaghan</name>
<name sortKey="Kish, Stephen J" sort="Kish, Stephen J" uniqKey="Kish S" first="Stephen J." last="Kish">Stephen J. Kish</name>
<name sortKey="Kish, Stephen J" sort="Kish, Stephen J" uniqKey="Kish S" first="Stephen J." last="Kish">Stephen J. Kish</name>
<name sortKey="Sykes, Jenna" sort="Sykes, Jenna" uniqKey="Sykes J" first="Jenna" last="Sykes">Jenna Sykes</name>
</country>
<country name="États-Unis"><noRegion><name sortKey="Cunningham, James K" sort="Cunningham, James K" uniqKey="Cunningham J" first="James K." last="Cunningham">James K. Cunningham</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001515 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001515 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:12-0064798
   |texte=   Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs

Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri